4.6 Article

Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology

期刊

JOURNAL OF PSYCHIATRIC RESEARCH
卷 46, 期 8, 页码 1093-1098

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jpsychires.2012.04.026

关键词

Schizophrenia; Interleukin; Cytokines; Immune

资金

  1. National Natural Science Foundation of China [81000509]
  2. Beijing Municipal Excellent Talents Foundation [2010D003034000032]
  3. Stanley Medical Research Institute [03T-459, 05T-726]
  4. United States National Institute of Health [K05-DA0454, P50-DA18827, U01-MH79639]

向作者/读者索取更多资源

Background: Schizophrenia is associated with various abnormalities in the immune system including elevated levels of Interleukin-18 (IL-18), a potent inflammatory cytokine in T-helper 1 (Th1) responses. The aim of this study was to assess the clinical significance of serum IL-18 levels in various stages of schizophrenia. Methods: We measured serum IL-18 levels using a sandwich enzyme-linked immunosorbent assay (ELISA) from 78 never-medicated first-episode schizophrenia, 79 medicated chronic schizophrenia and 78 healthy control subjects. The symptoms of schizophrenia were assessed by the Positive and Negative Syndrome Scale (PANSS). Results: The chronic patients had significantly greater serum IL-18 levels than both first-episode patients and controls. Serum IL-18 was also positively correlated with the PANSS general psychopathology subscore in chronic schizophrenic patients. Conclusions: Our results showed elevated IL-18 pathway activity may be involved in the psychopathology of schizophrenia. (C) 2012 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据